Skip to main content

ADVERTISEMENT

Jolynn Tumolo

News
12/22/2022
Jolynn Tumolo
“The SARS-CoV-2 vaccine has been reported to be a possible trigger for the development of multiple dermatologic conditions including prurigo nodularis,” researchers said.
“The SARS-CoV-2 vaccine has been reported to be a possible trigger for the development of multiple dermatologic conditions including prurigo nodularis,” researchers said.
“The SARS-CoV-2 vaccine has been...
12/22/2022
First Report Managed Care
News
12/22/2022
Jolynn Tumolo
A survey of 800 personal care workers revealed almost all of them had witnessed resident-to-resident aggression.
A survey of 800 personal care workers revealed almost all of them had witnessed resident-to-resident aggression.
A survey of 800 personal care...
12/22/2022
Annals of Long-Term Care
News
12/22/2022
Jolynn Tumolo
Study authors said underreporting of indirect costs likely means the economic burden on patients, payers, and society is higher than their findings suggest.
Study authors said underreporting of indirect costs likely means the economic burden on patients, payers, and society is higher than their findings suggest.
Study authors said...
12/22/2022
First Report Managed Care
News
12/21/2022
Jolynn Tumolo
A Class I recall of sodium bicarbonate injection 8.4% has been expanded to include 14 additional lots.
A Class I recall of sodium bicarbonate injection 8.4% has been expanded to include 14 additional lots.
A Class I recall of sodium...
12/21/2022
Pharmacy Learning Network
News
12/21/2022
Jolynn Tumolo
Researchers reviewed data from the MASTER and GRIFFIN trials to determine whether patients could undergo stem cell transplants after receiving induction therapy that included daratumumab and lenolidamide. 
Researchers reviewed data from the MASTER and GRIFFIN trials to determine whether patients could undergo stem cell transplants after receiving induction therapy that included daratumumab and lenolidamide. 
Researchers reviewed data from...
12/21/2022
First Report Managed Care
News
12/21/2022
Jolynn Tumolo
Using data from Aetna, investigators compared comorbidities in patients with multiple sclerosis who were enrolled in commercial vs Medicare Advantage plans. 
Using data from Aetna, investigators compared comorbidities in patients with multiple sclerosis who were enrolled in commercial vs Medicare Advantage plans. 
Using data from Aetna,...
12/21/2022
First Report Managed Care
News
12/21/2022
Jolynn Tumolo
For their research, study authors investigated how many patients had strokes while not receiving anticoagulants, as well as how many experienced hemorrhages after anticoagulation was resumed.
For their research, study authors investigated how many patients had strokes while not receiving anticoagulants, as well as how many experienced hemorrhages after anticoagulation was resumed.
For their research, study...
12/21/2022
Veterans Health Today
News
12/21/2022
Jolynn Tumolo
Rural caregivers of patients who take prescription opioids also prefer “EpiPen” better than “fire extinguisher” for analogies describing the emergency use of naloxone to reverse effects of opioids, according to a recent study.
Rural caregivers of patients who take prescription opioids also prefer “EpiPen” better than “fire extinguisher” for analogies describing the emergency use of naloxone to reverse effects of opioids, according to a recent study.
Rural caregivers of patients who...
12/21/2022
Addiction Professional
News
12/20/2022
Jolynn Tumolo
Researchers used clinic billing records in Washington, DC and Chicago to estimate the annual billable costs associated with the use of preexposure prophylaxis for HIV.
Researchers used clinic billing records in Washington, DC and Chicago to estimate the annual billable costs associated with the use of preexposure prophylaxis for HIV.
Researchers used clinic billing...
12/20/2022
First Report Managed Care
News
12/20/2022
Jolynn Tumolo
Researchers studied outcomes such as all-cause hospitalizations and psychiatric emergency department visits in patients treated with pimavanserin, quetiapine, risperidone, olanzapine, or aripiprazole. 
Researchers studied outcomes such as all-cause hospitalizations and psychiatric emergency department visits in patients treated with pimavanserin, quetiapine, risperidone, olanzapine, or aripiprazole. 
Researchers studied outcomes...
12/20/2022
Annals of Long-Term Care